Osteoporosis silently weakens bones, increasing the chance of a fracture from a simple fall. Evenity (romosozumab) is an injectable medication developed to help rebuild bone and lower that risk for certain adults. This article explains how Evenity works, who might be a candidate, and what to discuss with a healthcare provider.

How Evenity (Romosozumab) Works

Bone is living tissue that constantly breaks down and rebuilds. In osteoporosis, breakdown outpaces rebuilding, leaving bones porous and fragile. Romosozumab, the active ingredient in Evenity, works differently from many older treatments: it inhibits a protein called sclerostin, which normally slows bone formation. By blocking sclerostin, Evenity encourages new bone growth while also reducing the rate at which bone is broken down. According to the manufacturer's prescribing information, this dual action leads to a rapid increase in bone mineral density and a reduction in fracture risk after several months of treatment. For many patients, that can mean a meaningful improvement in bone strength during the 12-month treatment course.

Who May Benefit From Evenity?

Evenity is typically reserved for people at high risk of fracture, not as a first choice for everyone with osteoporosis. Your healthcare provider may consider it if you have already experienced a fragility fracture or if bone density testing shows very low bone mass. Candidates often include:

  • Postmenopausal women with a history of a low-trauma fracture
  • Those who have not responded adequately to other osteoporosis treatments
  • Individuals with a bone mineral density T-score of -2.5 or lower, especially with additional risk factors

Additionally, Evenity is given as two injections under the skin once a month for one year. After that, a doctor may recommend a different medication to maintain the bone gained. It is worth noting that other new medications, such as Veozah (fezolinetant), address separate health conditions and are not related to bone density treatment. Therefore, an open conversation with a specialist can help clarify which option fits your specific needs.

What to Consider Before Starting Treatment

Before beginning Evenity, your healthcare provider will review your medical history, including any past cardiovascular events or blood calcium issues, because these may influence whether the medication is appropriate. Some people may experience temporary injection site reactions or other mild effects; always report any new or unusual symptoms promptly. According to the Bone Health & Osteoporosis Foundation, ongoing monitoring and follow-up care are essential to ensure the best outcomes. The Centers for Disease Control and Prevention also emphasizes that fall prevention and adequate calcium and vitamin D intake remain important alongside any medication. Because Evenity is prescribed for a limited time, planning the transition to another therapy is a key part of the decision.

Evenity offers a unique dual-action approach for adults facing a high risk of osteoporotic fractures. By building bone more quickly than some older therapies, it may help reduce the chance of a life-changing fracture. If you or someone you know has experienced a fragility fracture or has been diagnosed with severe osteoporosis, consider discussing Evenity with a healthcare provider. Understanding your options can empower you to make informed choices about your bone health.